Gerhard Johann Frey

USPTO Granted Patents = 83 (Patent Applications = 41)

CIPO Patents = 13 (Patent Applications = 13)

EPO Patents = 32 (Patent Applications = 58)

Average Co-Inventor Count = 3.8

ph-index = 17

Forward Citations = 911(Granted Patents)

Inventors with similar research interests:

Location History:

St. Louis, MO (US) (2020)
San Diego, CA (US) (2001 - 2024)

Company Filing History:

Dana-farber-cancer Institute Inc.

Syngenta Participations Ag

patents

11. 2 out of 2

Femta Pharmaceuticals, Inc.

patents

12. 2 out of 2

Tioma Therapeutics, Inc.

Corvus Pharmaceuticals, Inc.

patents

15. 2 out of 2,595

University of Pennsylvania

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

Areas of Expertise:

Anti-EpCAM Antibodies

Chimeric Antigen Receptors

Anti-Ror2 Antibodies

Therapeutic CD47 Antibodies

Humanized Anti-CD73 Antibodies

Multi-Specific Monoclonal Antibodies

Anti-IL-22 Antibodies

Antibody Molecules to PD-1

Antibody Molecules to PD-L1

Conditionally Active Biological Proteins

Mirac Proteins

Anti-CTLA4 Antibodies

83 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12427347 - Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof (2025-09-30),

2. 12311032 - Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof (2025-05-27),

3. 12252535 - Antibody molecules to LAG-3 and uses thereof (2025-03-18),

4. 12187801 - Chimeric antigen receptors against AXL or ROR2 and methods of use thereof (2025-01-07),

5. 12186278 - Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy (2025-01-07),

6. 12110611 - Conditionally active biological proteins (2024-10-08),

7. 11897959 - Anti-AXL antibodies, antibody fragments and their immunoconjugates and uses thereof (2024-02-13),

8. 11879011 - Anti-ROR2 antibodies, antibody fragments, their immunoconjucates and uses thereof (2024-01-23),

9. 11859007 - Humanized anti-CD73 antibodies (2024-01-02),

10. 11851499 - Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof (2023-12-26),

11. 11834472 - Anti-IL-22 antibodies, antibody fragments, their immunoconjugates and uses thereof (2023-12-05),

12. 11827704 - Antibody molecules to PD-1 and uses thereof (2023-11-28),

13. 11773509 - Conditionally active polypeptides and methods of generating them (2023-10-03),

14. 11718844 - Mirac proteins (2023-08-08),

15. 11542332 - Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof (2023-01-03),

Title: Gerhard Johann Frey: Pioneering Inventor from San Diego

Introduction: Gerhard Johann Frey is a renowned inventor based in San Diego, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Gerhard Johann Frey holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, with his most recent patent focusing on advanced robotics for healthcare applications.

Career Highlights: Throughout his illustrious career, Gerhard Johann Frey has worked with leading tech companies to develop innovative solutions that have revolutionized industries. His expertise in merging technology with healthcare has led to significant advancements in patient care.

Collaborations: Gerhard Johann Frey has collaborated with top researchers, engineers, and medical professionals to bring his inventions to life. His ability to work across disciplines has resulted in cutting-edge products that have improved the quality of life for many.

Conclusion: Gerhard Johann Frey's passion for innovation and his dedication to pushing the boundaries of technology make him a standout figure in the world of inventors. His impact on various industries is truly remarkable, and his legacy continues to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.